Recently, the Jiangsu Federation of industry and Commerce released the "2024 Jiangsu Top 100 Private Enterprises" series of lists. Ask Pharm was successfully included in the "2024 Jiangsu Top 100 Private Enterprises in R&D Investment" list due to its outstanding R&D capabilities and technological achievements, highlighting the Ask Pharm's excellent performance in R&D innovation.
Ask Pharm is thriving and has strong vitality. In the "2024 list of The Top 100 Nanjing Manufacturing Enterprises” published by the Nanjing Enterprise Confederation, Ask Pharm has been included for five consecutive years.
Ask Pharm as an innovative and R&D-driven pharmaceutical manufacturing enterprise, has integrated innovation into its corporate DNA since its establishment, committed to technological advancement, and determined to pursue the "new." In recent years, we have continuously increased our investment in R&D, effectively advancing the development process of several innovative drugs.
In the future, Ask Pharm will continue to uphold the corporate philosophy of "Research as the Source, Health as the Foundation," constantly enhancing its innovation capabilities, researching and launching more high-quality new domestic drugs, and contributing to the high-quality development of Jiangsu's private economy with Ask's strengths!